Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Roche
Roche
Roche sees a slight dip in Q1 as biosimilars keep biting into blockbuster oncology trio's sales
Roche sees a slight dip in Q1 as biosimilars keep biting into blockbuster oncology trio's sales
Endpoints
Roche
earnings
biosimilars
Flag link:
Roche culls 2 COVID-19 drug hopefuls amid Q1 clear-out
Roche culls 2 COVID-19 drug hopefuls amid Q1 clear-out
Fierce Biotech
Roche
antibodies
COVID-19
Flag link:
Looking to cement its lead in packed MS market, Roche's Ocrevus uncorks new data in early-stage patients
Looking to cement its lead in packed MS market, Roche's Ocrevus uncorks new data in early-stage patients
Endpoints
Roche
Ocrevus
MS
multiple sclerosis
clinical trials
Flag link:
6 medtechs to watch when earnings kick off next week
6 medtechs to watch when earnings kick off next week
Medtech Dive
earnings
devices
Abbott Labs
Edwards Lifesciences
Intuitive Surgical
JNJ
Roche
Quest Diagnostics
Flag link:
Novartis inks 3rd COVID-19 production pact, this time for Roche's arthritis med Actemra
Novartis inks 3rd COVID-19 production pact, this time for Roche's arthritis med Actemra
Fierce Pharma
Novartis
COVID-19
Pfizer
BioNTech
CureVac
Roche
API
Actemra
Flag link:
Evrysdi has ‘real world impact’ on lives of babies with severe SMA, says Roche
Evrysdi has ‘real world impact’ on lives of babies with severe SMA, says Roche
Pharmaforum
Roche
Genentech
Evrysdi
SMA
Flag link:
Senti Biosciences in $645M Spark pact to drive gene circuits into the fast lane
Senti Biosciences in $645M Spark pact to drive gene circuits into the fast lane
Fierce Biotech
Spark Therapeutics
Senti Biosciences
Roche
gene circuits
gene therapy
Flag link:
5 takeaways from AACR, one of the year's top meetings on cancer drugs
5 takeaways from AACR, one of the year's top meetings on cancer drugs
BioPharma Dive
AACR
CAR-T
Merck
Roche
Sanofi
Synthorx
Eli Lilly
Bristol Myers Squibb
Flag link:
Pharma's pandemic reputation gains score a 'most-improved' medal in annual ranking
Pharma's pandemic reputation gains score a 'most-improved' medal in annual ranking
Fierce Pharma
reputation
pharma industry
Sanofi
Novo Nordisk
Roche
Eli Lilly
Bristol Myers Squibb
Flag link:
Genentech aims high with new diversity goals, including doubling hires and spending $1B with diverse suppliers
Genentech aims high with new diversity goals, including doubling hires and spending $1B with diverse suppliers
Fierce Pharma
Roche
Genentech
diversity
Flag link:
Go or no go? The FDA plays hardball
Go or no go? The FDA plays hardball
EP Vantage
FDA
Pfizer
Roche
Merck
Bristol Myers Squibb
accelerated approvals
Flag link:
Why Roche's $1.8 Billion Acquisition of GenMark Is a Smart Move
Why Roche's $1.8 Billion Acquisition of GenMark Is a Smart Move
Motley Fool
Roche
GenMark
M&A
Flag link:
Regeneron and Roche's antibody cocktail shown helping in COVID-19 cases
Regeneron and Roche's antibody cocktail shown helping in COVID-19 cases
Reuters
Regeneron
Roche
clincial trials
COVID-19
Flag link:
Roche cuts bait on late-stage study of Huntington's med tominersen, an Ionis import with prior safety flags
Roche cuts bait on late-stage study of Huntington's med tominersen, an Ionis import with prior safety flags
Endpoints
Roche
Huntington's disease
tominersen
Flag link:
Roche's Tecentriq is the first I-O drug to claim a post-surgery win in lung cancer. But will doctors use it?
Roche's Tecentriq is the first I-O drug to claim a post-surgery win in lung cancer. But will doctors use it?
Fierce Pharma
Roche
Tecentriq
non-small cell lung cancer
Flag link:
Horizon, Roche's Genentech, AbbVie and Neurocrine rank as top pharma places to work in annual poll
Horizon, Roche's Genentech, AbbVie and Neurocrine rank as top pharma places to work in annual poll
Fierce Pharma
Horizon Therapeutics
Roche
Genentech
AbbVie
Neurocrine
employee satisfaction
Flag link:
Potential False Results with Roche Molecular Systems’ SARS-CoV-2 Assay
Potential False Results with Roche Molecular Systems’ SARS-CoV-2 Assay
FDA Law Blog
Roche Molecular Systems
COVID-19
diagnostics
Roche
Flag link:
Roche launches test to monitor emerging coronavirus variants
Roche launches test to monitor emerging coronavirus variants
Pharmaforum
Roche
diagnostics
COVID-19
COVID-19 variants
Flag link:
Roche drops $1.85B for GenMark's testing tech as pandemic, antibiotic resistance threats loom
Roche drops $1.85B for GenMark's testing tech as pandemic, antibiotic resistance threats loom
Endpoints
Roche
Genentech
M&A
GenMark Diagnostics
diagnostics
Flag link:
GSK, Novo and Roche meds hit pandemic potholes while Dupixent, Humira stood strong: analysts
GSK, Novo and Roche meds hit pandemic potholes while Dupixent, Humira stood strong: analysts
Fierce Pharma
COVID-19
pandemic
GSK
Novo Nordisk
Roche
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »